| Literature DB >> 30892760 |
Cees Valkenburg1, Fridus A Van der Weijden1, Dagmar E Slot1.
Abstract
This paper focuses on plaque control and the management of gingivitis in adults and summarizes the evidence of commercially available dentifrices as gathered from existing systematic reviews. Three internet sources were used to search for appropriate papers (up to and including February 2017). The search strategy was designed to include any systematic review published on dentifrices that also included an evaluation of plaque and gingivitis scores. Characteristics of the individual reviews, such as methodological aspects, quantitative data and conclusions, were extracted. The potential risk of bias was estimated and the acquired evidence was graded. Independent screening of 205 unique reviews resulted in 10 published and eligible systematic reviews. One publication evaluated the mechanical contribution of dentifrice to plaque removal. Eight papers were identified that evaluated the efficacy of a proposed single active ingredients, of which two reviewed more than one potentially active ingredient. One study compared two active ingredients. This meta-review appraised the current state of evidence and found that toothbrushing with a standard fluoride dentifrice does not provide an added effect for the mechanical removal of dental plaque. Evidence suggests that compared with a standard dentifrice, those containing triclosan or stannous fluoride have benefits with respect to gingival health and control of dental plaque.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30892760 PMCID: PMC7328759 DOI: 10.1111/prd.12257
Source DB: PubMed Journal: Periodontol 2000 ISSN: 0906-6713 Impact factor: 7.589
Figure 1Search and selection results. *Some studies provide more than one ingredient
Overview of data extraction of the included systematic reviews regarding plaque index scores and gingival index
| Source | Index | Outcomes | Heterogeneity | |||||
|---|---|---|---|---|---|---|---|---|
| Ingredient | Systematic review | No. experiments in meta‐analysis | DiffM | 95% CI |
|
|
| |
|
| ||||||||
| Dentifrice | Valkenburg et al | 18 | Q&H | 0.00 | −0.05; 0.05 | .91 | 0 | .57 |
| CHX | Serrano et al | 4 | Q&H Turesky | −0.687 | −1.317; −0.057 | .000 | 97.4 | .000 |
| CHX | Escribano et al | 3 | Q&H Turesky | −0.81 | −1.74; 0.12 | .09 | 98.2 | ? |
| SnF | Paraskevas and Van der Weijden | 4 | Q&H Turesky | −0.31 | −0.54; −0.07 | .01 | 91.7 | <.0001 |
| SnF | Gunsolley | 5 | Q&H | −0.168■ | ? | .007 | ? | ? |
| SnF | Serrano et al | 3 | Q&H Turesky | −0.112 | −0.185; 0.040 | .002 | 61.4 | .062 |
| SnF | Escribano et al | 5 | Q&H Turesky | −0.28 | −0.49; −0.07 | .01 | 90.7 | ? |
| Triclosan‐COP | Serrano et al | 18 | Q&H Turesky | −0.447 | −0.594; −0.300 | .000 | 95.4 | .000 |
| Triclosan‐COP | Escribano et al | 16 | Q&H Turesky | −0.49 | −0.60; −0.28 | .00 | 94.2 | ? |
| Triclosan‐COP | Hioe and Van der Weijden | 9 | Q&H Turesky | −0.48 | −0.73; −0.24 | <.0001 | 97.2 | <.00001 |
| Triclosan‐COP | Davies et al | 15 | Q&H | −0.48 | −0.64; −0.32 | <.00001 | 95.7 | <.00001 |
| Triclosan‐COP | Riley and Lamont | 20 | Q&H | −0.47 | −0.60; −0.34 | <.00001 | 94 | <.00001 |
| Triclosan‐COP | Gunsolley | 18 | Q&H Turesky | −0.823■ | ? | <.00 | ? | ? |
| Triclosan‐ZnCIT | Gunsolley | 2 | Q&H Turesky | ? | ? | .551 | ? | ? |
| Triclosan‐PYRO | Gunsolley | 4 | Q&H Turesky | ? | ? | .040 | ? | ? |
| Triclosan‐COP | Serrano et al | 3 | S&L | −0.139 | −0.371; 0.094 | .242 | 96.7 | .000 |
| Triclosan‐COP | Riley and Lamont | 2 | L&S | −0.05 | −0.10; −0.01 | .027 | 8 | .30 |
| Triclosan‐ZnCIT | Hioe and Van der Weijden | 6 | S&L | −0.07 | −0.10; −0.05 | <.00001 | 0 | .53 |
| Triclosan‐ZnCIT | Serrano et al | 6 | S&L | −0.095 | −0.186; −0.005 | .000 | 89.2 | .000 |
| Triclosan‐PYRO | Serrano et al | 2 | S&L | −0.002 | −0.056; 0.060 | .953 | 0 | .739 |
| SnF vs triclosan | Sälzer et al | 7 | Q&H | −0.29 | −0.45; −0.13 | <.001 | 90 | <.001 |
| 4 | RMNPI | 0.09 | −0.01; 0.18 | .07 | 97 | <.001 | ||
|
| ||||||||
| CHX | Serrano et al | 4 | L&S | −0.289 | −0.558; −0.021 | .000 | 92.8 | .000 |
| SnF | Paraskevas and Van der Weijden | 6 | L&S | −0.15 | −0.20; −0.11 | <.00001 | 91.1 | <.00001 |
| SnF | Gunsolley | 6 | L&S | −0.441■ | ? | .000 | ? | .010 |
| SnF | Serrano et al | 2 | L&S | −0.115 | −0.161; −0.069 | .000 | 64.8 | .092 |
| SnF AMIN | Serrano et al | 2 | L&S | −0.059 | −0.074; −0.044 | .000 | 26.5 | .243 |
| Triclosan‐COP | Serrano et al | 16 | L&S | −0.241 | −0.304; −0.178 | .000 | 91.2 | .000 |
| Triclosan‐COP | Hioe and Van der Weijden | 8 | L&S | −0.24 | −0.35; −0.13 | <.0001 | 98.3 | <.00001 |
| Triclosan‐COP | Davies et al | 14 | L&S | −0.26 | −0.34; −0.18 | <.00001 | 96.5 | <.00001 |
| Triclosan‐COP | Riley and Lamont | 20 | L&S | −0.27 | −0.33; −0.21 | <.00001 | 95 | <.00001 |
| Triclosan‐COP | Gunsolley | 16 | L&S | −0.858■ | ? | .000 | ? | <.001 |
| Triclosan‐PYRO | Gunsolley | 3 | L&S | ? | ? | .647 | ? | ? |
| SnF | Gunsolley | 2 | MGI | ? | ? | .000 | ? | ? |
| SnF‐HEXA | Serrano et al | 2 | MGI | −0.382 | −0.449; −0.315 | .000 | 60.3 | .112 |
| SnF‐SHMP | Serrano et al | 2 | BOP | −4.666 | −6.984; −2.347 | .000 | 82.5 | .017 |
| Triclosan‐COP | Serrano et al | 2 | BOP | −3.153 | −9.128; 2.821 | .301 | 65.8 | .087 |
| Triclosan‐PYRO | Serrano et al | 2 | BOP | −4.344 | −12.366; 3.677 | .288 | 77.4 | .036 |
| Triclosan‐ZnCIT | Hioe and Van der Weijden | 4 | BOP | −10.81 | −12.69; −8.93 | <.00001 | 0 | .48 |
| ZnCIT | Serrano et al | 5 | BOP | −9.301 | −12.875; −5.727 | .000 | 76.8 | .002 |
| SnF vs triclosan | Sälzer et al | 14 | L&S | −0.04 | −0.11; 0.04 | .34 | 97 | <.001 |
| 7 | GBI | 0.02 | 0.01; 0.03 | <.001 | 67 | .01 | ||
BOP, bleeding on probing81; CHX, chlorhexidine; COP, copolymer; GBI, Gingival Bleeding Index82; L&S, Loë‐Silness gingivitis index31; MGI, Modified Gingival Index80; RMNPI, Rustogi Modification of Navy Plaque Index33; S&L, Silness‐Löe plaque index32; SnF, stannous fluoride; Q&H, Quigley and Hein plaque index28; ZnCIT, zinc citrate; ?: unknown; ■: standardized mean difference; PYRO, pyrophosphates; AMIN, amin fluoride; HEXA, hexametaphosphate; SHMP, sodium hexametaphosphate.
*P value > 0.1 not significant.
Heterogeneity within the meta‐analysis can be tested by chi‐squared test and I 2 statistic. A chi‐squared test resulting in P < 0.1 was considered an indication of significant statistical heterogeneity. As a rough guide for assessing the possible magnitude of inconsistency across studies, an I 2 statistic of 0%‐40% can be interpreted as not important; above 40% moderate (40%‐80%) to considerable (>80%) heterogeneity may be present.83
Summary of the calculated point estimate and measure of variability for the weighted means of the mean differences obtained from systematic reviews ordered by index and ingredient, presented compared with placebo/control as a weighed mean, SDs of the weighted mean in parentheses and corresponding 95% confidence intervals (CI)
| Index | Ingredient | Number of meta‐analyses | Point estimate and measure of variability | |
|---|---|---|---|---|
| Mean (SD) | 95% CI | |||
|
Quigley and Hein plaque index | Stannous fluoride | 3 | 0.25 (0.08) | 0.20; 0.29 |
| Triclosan copolymer | 5 | 0.47 (0.02) | 0.47; 0.48 | |
| Chlorhexidine | 2 | 0.73 (0.07) | 0.70; 0.79 | |
|
Silness and Loe plaque index | Triclosan copolymer | 2 | 0.10 (0.05) | 0.07; 0.14 |
| Triclosan zinc citrate | 2 | 0.08 (0.01) | 0.08; 0.09 | |
|
Loe and Silness gingival index | Stannous fluoride | 2 | 0.14 (0.02) | 0.13; 0.15 |
| Triclosan copolymer | 4 | 0.26 (0.01) | 0.25; 0.26 | |
Estimated risk of bias by scoring a list of items related to the reporting and methodological quality of the included systematic reviews
| Ingredient | General | Aloe vera | CHX | SnF | Triclosan | Various | Comparison | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Author | |||||||||||
| Valkenburg et al | Dhingra | Slot et al | Paraskevas and Van der Weijden | Davies et al | Hioe and Van der Weijden | Riley and Lamont | Gunsolley | Serrano et al | Escribano et al | Sälzer et al | |
| Criteria | |||||||||||
| Current authors estimated quality score, % | 93 | 76 | 85 | 59 | 63 | 48 | 96 | 44 | 85 | 85 | 93 |
| Current authors estimated risk of bias | Low | Moderate | Low | Substantial | Moderate | Substantial | Low | Substantial | Low | Low | Low |
For the quality assessment score individual items with a positive rating were summed to obtain an overall percentage score.
Items scored as reported by Sälzer et al.84
Estimated evidence profile (GRADE 2011)19, 38 for the effect of various active ingredients of dentifrices on dental plaque and gingival health
| GRADE | Aloe vera | Chlorhexidine | Triclosan | Stannous fluoride |
|---|---|---|---|---|
| Study designs | Systematic review N = 2 | Systematic review N = 3 | Systematic review N = 7 | Systematic review N = 5 |
| Reporting and methodological estimated potential risk of bias | Low to moderate | Low | Low to substantial | Low to substantial |
| Consistency | Inconsistent | Fairly consistent | Consistent | Consistent |
| Heterogeneity | Considerable | Considerable | Considerable | Considerable |
| Directness | Indirect | Direct | Direct | Direct |
| Precision | Imprecise | Precise | Precise | Precise |
| Publication bias | Possible | Possible | Possible | Possible |
| Magnitude of the effect | Very small | Small | Moderate | Moderate |
| Body of evidence | Very weak | Weak | Strong | Strong |
GRADE, Grading of Recommendations Assessment, Development and Evaluation.